On February 24, 2026, the Legislative Regulation Review Committee unanimously approved regulations to update the controlled substance drug schedule for several substances, including Mitragyna Speciosa, also known as Kratom. Connecticut is the seventh state to designate Kratom and its derivatives, including 7-OH, as Schedule 1 controlled substances.
The proposed regulations are available for review on the Connecticut Secretary of the State website.
Business Owners
Business owners are advised to immediately remove from shelves all products recently designated Schedule 1 Controlled Substances. Products should be destroyed or returned to their wholesaler by March 25, 2026.
In addition to mitragyna speciosa (kratom), including its leaves, stem and any extracts, the following substances have also been designated as schedule 1 controlled substances:
- 7-hydroxymitragynine (7-OH, a kratom derivative)
- Bromazolam
- Flubromazolam
- Nitazenes, including, but not limited to, isotonitazene
- Tianeptine
- Phenibut
More information for businesses:
- Department of Consumer Protection Releases Guidance for Businesses Regarding Controlled Substance Drug Schedule Updates (March 4, 2026)
Legislative Regulation Review Committee Meeting, February 24, 2026
The Legislative Regulation Review Committee unanimously approved regulations to update the controlled substance drug schedule for several substances, including Mitragyna Speciosa, also known as Kratom.
- Department of Consumer Protection Applauds Passage of Controlled Substance Drug Schedule Updates (February 24, 2026)
Public Hearing Held October 15, 2025
A virtual public hearing regarding the scheduling of kratom as a Schedule 1 controlled substance in Connecticut was held on Wednesday, October 15, 2025. Comments were shared at the public hearing on October 15, 2025 and submitted via written public comment.